Correction: Cost comparison of nine-month treatment regimens with 20-month standardized care for the treatment of rifampicin-resistant/multi-drug resistant tuberculosis in Nigeria
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsTuberculosis Research and Epidemiology
The affiliation for the fourth author is incorrect. Saswata Dutt is not affiliated with #4 but with #5:
Department of Prevention, Care and Treatment, Institute of Human Virology, Abuja, Nigeria.
The publisher apologizes for the error.
The reference list from the paper itself. Each links out to its DOI / PubMed record.
- 1Bada FO, Blok N, Okpokoro E, Dutt S, Akolo C, Dakum P, et al. Cost comparison of nine-month treatment regimens with 20-month standardized care for the treatment of rifampicin-resistant/multi-drug resistant tuberculosis in Nigeria. P Lo S One. 2020;15(12): e 0241065. doi: 10.1371/journal.pone.0241065 33259492 PMC 7707487 · doi ↗ · pubmed ↗